Search
for

    Sort by

    Research 151–180 of 1000+

    1. Managing Cutaneous Manifestations of Hyperandrogenic Disorders Treatments in endocrinology · 2002 · 22 citations
    2. Detection of Male Hypogonadism in Patients with Post COVID-19 Condition Journal of clinical medicine · 2022 · 20 citations
    3. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China Journal of Cosmetic Dermatology · 2017 · 17 citations
    4. MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis European Journal of Endocrinology · 2018 · 16 citations
    5. Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction. PubMed · 2012 · 13 citations
    6. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism. PubMed · 2000 · 10 citations
    7. The role of androgen therapy Best Practice & Research in Clinical Obstetrics & Gynaecology · 2002 · 9 citations
    8. PREVALENCE AND PREDICTORS OF METABOLIC SYNDROME IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME- A STUDY FROM SOUTHERN INDIA International journal of reproduction, contraception, obstetrics and gynecology · 2015 · 6 citations
    9. Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients Anais Brasileiros De Dermatologia · 2022 · 3 citations
    10. Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS) Journal of Steroids & Hormonal Science · 2016 · 2 citations
    11. Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation International Journal of Drug Delivery Technology · 2025 · 1 citations
    12. The impact of levothyroxine on thyroid autoimmunity and hypothalamic–pituitary–thyroid axis activity in men with autoimmune hypothyroidism and early-onset androgenetic alopecia Endokrynologia Polska · 2021 · 1 citations
    13. Assessment of androgenic hormones and other risk factors in Egyptian males with early onset androgenetic alopecia: a case control study Archives of Dermatological Research · 2025
    14. Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes Human Reproduction Open · 2025
    15. The effect of gonadoliberin analog treatment in precocious puberty on polycystic ovarian syndrome prevalence in adulthood Frontiers in endocrinology · 2024
    16. INFLUENCE OF LIFESTYLE ON THE PROGNOSIS OF POLYCYSTIC OVARY SYNDROME Health and Society · 2021
    17. Correlation of cutaneous findings and sonographic ovarian morphology in polycystic ovarian syndrome IP Indian journal of clinical and experimental dermatology · 2020
    18. Cutaneous xanthomas in homozygous familial hypercholesterolemia: A 12-year follow-up Journal of The American Academy of Dermatology · 2016
    19. Cutaneous metastasis from colonic adenocarcinoma: Mimicker of infectious etiology Journal of The American Academy of Dermatology · 2016
    20. Correlation of androgenetic alopecia and early onset coronary heart disease in men. Scientific journal of Kurdistan University of Medical Sciences · 2015
    21. Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    22. Practical approaches to the use of markers of biochemical hyperandrogenism in women Reproductive Endocrinology · 2022 · 1 citations
    23. Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes Scientific Reports · 2017 · 54 citations
    24. Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride Endocrine Regulations · 2010 · 24 citations
    25. Male Equivalent Polycystic Ovarian Syndrome: Hormonal, Metabolic, and Clinical Aspects. DOAJ (DOAJ: Directory of Open Access Journals) · 2020 · 12 citations
    26. Androgens and women's health. PubMed · 1998 · 5 citations
    27. Berberine as a Modulator of Metabolic and Hormonal Dysregulation in PCOS: Mechanisms of Action and Clinical Implications - A Narrative Review Quality in Sport · 2026
    28. Trazodone by epigenetic mechanism can reverse the post finasteride syndrome Magna Scientia Advanced Research and Reviews · 2023
    29. Tratamento das manifestações androgênicas Femina · 2019
    30. Андрогенетическая алопеция: патогенетические механизмы и подходы к лечению Российский журнал кожных и венерических болезней · 2013